Guidelines for the Endoscopic Diagnosis of Ulcerative Colitis Are Not Followed in a Substantial Proportion of Patients: Real‐World Use of Colonoscopy Versus Sigmoidoscopy—A Copenhagen Inflammatory Bowel Disease Inception Cohort Study
Open Access
Abstract
Background and Aims: Evaluating whether international endoscopic diagnostic guideline recommendations regarding ulcerative colitis are followed in routine clinical practice, and assessing the clinical value of performing a follow‐up ileocolonoscopy in patients diagnosed based on a sigmoidoscopy. Methods: This observational cohort study included all newly diagnosed adult patients with ulcerative colitisdiagnosed between May 1, 2021, and April 30, 2023, from The Copenhagen Inflammatory Bowel Disease Inception Cohort. The study included both patients with the initial endoscopic procedure done at a hospital or a private practice and three guideline‐adherent work‐up criteria were defined. Results: In total, 300 patients fulfilled inclusion criteria. Initial ileocolonoscopy with biopsies was performed in 190 patients, and among 101 patients with an initial sigmoidoscopy (including eight presenting with acute severe ulcerative colitis), 34 patients had a follow‐up ileocolonoscopy performed within 15 months. In total, 147 patients (49%) fulfilled the guideline‐adherent work‐up criteria. No significant differences were found when comparing, CRP, and fecal calprotectin, among other parameters, between patients who did and did not have a follow‐up ileocolonoscopy performed after the initial sigmoidoscopy. Conclusion: Half of the patients fulfilled the guideline‐adherent work‐up criteria. Nonadherence to the defined guideline criteria was mainly the absence of a follow‐up ileocolonoscopy within 15 months. Guideline adherence differed considerably between hospitals and private practitioners underscoring the need for improved diagnostic standardization. No significant differences were found between patients with and without follow‐up ileocolonoscopy after initial sigmoidoscopy.Keywords
Funding Information
- Novo Nordisk Fonden (NNF20OC0059377)
This publication has 14 references indexed in Scilit:
- ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1Journal of Crohn's and Colitis, 2025
- ECCO Guidelines on Inflammatory Bowel Disease and MalignanciesJournal of Crohn's and Colitis, 2022
- The Rising Burden of Inflammatory Bowel Disease in Denmark Over Two Decades: A Nationwide Cohort StudyGastroenterology, 2022
- Occurrence of Colorectal Cancer and the Influence of Medical Treatment in Patients With Inflammatory Bowel Disease: A Danish Nationwide Cohort Study, 1997 to 2015Inflammatory Bowel Diseases, 2021
- Changes in inflammatory bowel disease subtype during follow-up and over time in 44,302 patientsScandinavian Journal of Gastroenterology, 2019
- Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre studyGut, 2017
- Proximal Disease Extension in Patients With Limited Ulcerative Colitis: A Danish Population-based Inception CohortJournal of Crohn's and Colitis, 2017
- The Montreal classification of inflammatory bowel disease: controversies, consensus, and implicationsGut, 2006
- Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south eastern Norway.Gut, 1997
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987